Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1CETIRIZINE HYDROCHLORIDE

02 2GOSERELIN (GOSERELIN ACETATE)

03 2GOSERELIN ACETATE

04 2MELOXICAM

05 2ROLAPITANT HYDROCHLORIDE

06 1TELOTRISTAT ETIPRATE

07 4ZICONOTIDE ACETATE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : QUZYTTIR

2024 ACI Convention
Not Confirmed
arrow

Brand Name : QUZYTTIR

arrow
2024 ACI Convention
Not Confirmed

TerSera Therapeutics

Dosage Form : SOLUTION;INTRAVENOUS

Brand Name : QUZYTTIR

Dosage Strength : 10MG/ML (10MG/ML)

Packaging :

Approval Date : 2019-10-04

Application Number : 211415

Regulatory Info : RX

Registration Country : USA

blank

02

Brand Name : ZOLADEX

2024 ACI Convention
Not Confirmed
arrow

Brand Name : ZOLADEX

arrow
2024 ACI Convention
Not Confirmed

TerSera Therapeutics

Dosage Form : IMPLANT

Brand Name : ZOLADEX

Dosage Strength : 3.6MG

Packaging : ONE DEPOT

Approval Date :

Application Number : 2049325

Regulatory Info : Prescription

Registration Country : Canada

blank

03

Brand Name : ZOLADEX LA

2024 ACI Convention
Not Confirmed
arrow

Brand Name : ZOLADEX LA

arrow
2024 ACI Convention
Not Confirmed

TerSera Therapeutics

Dosage Form : IMPLANT

Brand Name : ZOLADEX LA

Dosage Strength : 10.8MG

Packaging : ONE DEPOT

Approval Date :

Application Number : 2225905

Regulatory Info : Prescription

Registration Country : Canada

blank

04

Brand Name : ZOLADEX

2024 ACI Convention
Not Confirmed
arrow

Brand Name : ZOLADEX

arrow
2024 ACI Convention
Not Confirmed

TerSera Therapeutics

Dosage Form : IMPLANT;IMPLANTATION

Brand Name : ZOLADEX

Dosage Strength : EQ 3.6MG BASE

Packaging :

Approval Date : 1989-12-29

Application Number : 19726

Regulatory Info : RX

Registration Country : USA

blank

05

Brand Name : ZOLADEX

2024 ACI Convention
Not Confirmed
arrow

Brand Name : ZOLADEX

arrow
2024 ACI Convention
Not Confirmed

TerSera Therapeutics

Dosage Form : IMPLANT;IMPLANTATION

Brand Name : ZOLADEX

Dosage Strength : EQ 10.8MG BASE

Packaging :

Approval Date : 1996-01-11

Application Number : 20578

Regulatory Info : RX

Registration Country : USA

blank

06

Brand Name : QMIIZ ODT

2024 ACI Convention
Not Confirmed
arrow

Brand Name : QMIIZ ODT

arrow
2024 ACI Convention
Not Confirmed

TerSera Therapeutics

Dosage Form : TABLET, ORALLY DISINTEGR...

Brand Name : QMIIZ ODT

Dosage Strength : 7.5MG **Federal Regist...

Packaging :

Approval Date : 2018-10-19

Application Number : 211210

Regulatory Info : DISCN

Registration Country : USA

blank

07

Brand Name : QMIIZ ODT

2024 ACI Convention
Not Confirmed
arrow

Brand Name : QMIIZ ODT

arrow
2024 ACI Convention
Not Confirmed

TerSera Therapeutics

Dosage Form : TABLET, ORALLY DISINTEGR...

Brand Name : QMIIZ ODT

Dosage Strength : 15MG **Federal Registe...

Packaging :

Approval Date : 2018-10-19

Application Number : 211210

Regulatory Info : DISCN

Registration Country : USA

blank

08

Brand Name : VARUBI

2024 ACI Convention
Not Confirmed
arrow

Brand Name : VARUBI

arrow
2024 ACI Convention
Not Confirmed

TerSera Therapeutics

Dosage Form : TABLET;ORAL

Brand Name : VARUBI

Dosage Strength : EQ 90MG BASE

Packaging :

Approval Date : 2015-09-01

Application Number : 206500

Regulatory Info : RX

Registration Country : USA

blank

09

Brand Name : VARUBI

2024 ACI Convention
Not Confirmed
arrow

Brand Name : VARUBI

arrow
2024 ACI Convention
Not Confirmed

TerSera Therapeutics

Dosage Form : EMULSION;INTRAVENOUS

Brand Name : VARUBI

Dosage Strength : EQ 166.5MG BASE/92.5ML...

Packaging :

Approval Date : 2017-10-25

Application Number : 208399

Regulatory Info : DISCN

Registration Country : USA

blank

10

Brand Name : XERMELO

2024 ACI Convention
Not Confirmed
arrow

Brand Name : XERMELO

arrow
2024 ACI Convention
Not Confirmed

TerSera Therapeutics

Dosage Form : TABLET;ORAL

Brand Name : XERMELO

Dosage Strength : EQ 250MG BASE

Packaging :

Approval Date : 2017-02-28

Application Number : 208794

Regulatory Info : RX

Registration Country : USA

blank